Effect of Levofloxacin and Azithromycin in bronchiectasis patients treatment

The preventive effects of short-course treatment with Levofloxacin in comparison with Azithromycin in bronchiectasis patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190109042312N1

Enrollment

Registered

2019-02-19

Start date

2019-02-19

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis. Bronchiectasis

Interventions

Intervention 1: Intervention group: Levofloxacin - In this group, patients will receive Levofloxacin for 5 days with the dose of 500mg in a month and will be followed for one year, during that time t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having a definitive diagnosis of bronchiectasis Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Having cystic fibrosis, allergies, asthma, tuberculosis

Design outcomes

Primary

Measure	Time frame
Exacerbation. Timepoint: During and after the end of the data collection. Method of measurement: By the form of information.	—

Secondary

Measure	Time frame
Number of admissions. Timepoint: During and after the end of the data collection. Method of measurement: By the form of information.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzane Peykfalak

Zahedan University of Medical Sciences

farzane_p471@zaums.ac.ir+98 54 3329 5789

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026